This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ge Healthcare Limited. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Marit Rolandsgard: Innovator in Radiopharmaceuticals
Introduction
Marit Rolandsgard is a notable inventor based in Oslo, Norway. She has made significant contributions to the field of radiopharmaceuticals, particularly in the preparation of amino acid derivatives used in medical imaging.
Latest Patents
Marit holds a patent for the "Preparation of a 1-amino-3-hydroxy-cyclobutane-1-carboxylic acid derivative." This invention relates to a process for preparing radiopharmaceutical precursors, specifically protected amino acid derivatives. These derivatives are essential for producing radiolabelled amino acids used in in vivo imaging procedures, such as positron emission tomography (PET). The patent ensures that the reaction efficiently goes to completion, enhancing the production of the [F]-1-amino-3-fluorocyclobutanecarboxylic acid ([F] FACBC) PET agent.
Career Highlights
Marit is currently employed at GE Healthcare Limited, where she continues to advance her research in the field of radiopharmaceuticals. Her work has been instrumental in improving imaging techniques that are vital for medical diagnostics.
Collaborations
Marit collaborates with Steven Michael Fairway, contributing to innovative projects in the healthcare sector.
Conclusion
Marit Rolandsgard's work in radiopharmaceuticals exemplifies the impact of innovation in medical imaging. Her contributions are paving the way for advancements in diagnostic procedures that benefit patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile